Christopher Dinsmore, Chief Scientific Officer at Kronos Bio, Inc. (KRON), sold 18,378 shares at $20.81 ($382K) on 2021-10-04, disclosed to the SEC on 2021-10-04.
Open-market sale of $382k KRON by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.81 | 9,189 | $191K | 50.0% |
| 2 | $20.81 | 9,189 | $191K | 50.0% |
| Total | $20.81 avg | 18,378 | $382K | 100% |
| Filing → |
| KRON | SELL | 2023-07-07 | $12K | — | Filing → |
| KRON | SELL | 2023-02-24 | $11K | — | Filing → |
| KRON | SELL | 2022-12-14 | $17K | — | Filing → |